GENMAB HOLDING B V has a total of 16 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BOSTON PHARMACEUTICALS INC, IMAGINAB INC and BIOATLA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Singapore | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | China | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Oostindie Simone | 12 |
#2 | Taylor Ronald | 12 |
#3 | Beurskens Frank | 12 |
#4 | Mutis Tuna | 12 |
#5 | Parren Paul | 12 |
#6 | Lindorfer Margaret | 12 |
#7 | Breij Esther | 12 |
#8 | Van Der Horst Hilma | 12 |
#9 | Overdijk Marije | 10 |
#10 | Van Den Brink Edward | 10 |
Publication | Filing date | Title |
---|---|---|
WO2020070313A1 | Pharmaceutical compositions comprising bispecific anti-cd37 antibodies | |
WO2019243636A1 | Anti-cd37 antibodies and anti-cd20 antibodies, compositions and methods of use thereof | |
AU2018242227A1 | Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof |